The effects of oxytocin and progestagens on myometrial contractility in vitro during equine pregnancy.

Aug 5, 2010Journal of reproduction and fertility. Supplement

Oxytocin and progestagens influence uterine muscle contractions during horse pregnancy

AI simplified

Circadian Biology on OpenScience ↗PubMed ↗

Abstract

In vitro testing of myometrial samples from 33 pregnant mares revealed no spontaneous contractile activity within 180 minutes.

Oxytocin treatment caused a significant dose-dependent increase in myometrial resting tension.
The amplitude of myometrial contractions tended to increase while frequency tended to decrease with higher oxytocin concentrations, though not significantly.
No correlation was found between gestational age and the amplitude or frequency of myometrial contractions.
Progestagens did not affect the amplitude or frequency of contractions when administered with or without oxytocin or prior to its treatment.
Findings suggest that progestagens may not play a role in regulating myometrial contractility in vitro, indicating the potential involvement of other hormones.

AI simplified

Progesterone or progestagens are thought to maintain myometrial quiescence in pregnant mares, although this has not been proven. In the present study, the contractility of the equine myometrium was tested in vitro using samples collected from pregnant mares (n=33) between day 68 and day 340 of gestation. Myometrial samples were equilibrated in aerated Krebs buffer and subjected to one or more of these treatments: (i) oxytocin only; (ii) initial oxytocin treatment followed by combined oxytocin and progesterone or another progestagen; and (iii) initial oxytocin treatment followed by Krebs buffer followed by progestagen; (iv) initial progesterone treatment followed by progesterone and oxytocin. Spontaneous contractile activity did not occur within 180 min. The oxytocin-only treatment resulted in a significant (P < 0.01) dose-dependent increase in myometrial resting tension. Myometrial contraction amplitude and frequency tended to increase and decrease, respectively, with increasing concentrations of oxytocin, but the effect was not significant. However, there was no correlation between the amplitude and frequency of myometrial contractions and gestational age. Treatment with progestagens did not alter the amplitude or frequency of oxytocin-stimulated myometrial contractions, regardless of whether progestagens were given with oxytocin (treatment (ii)), without oxytocin (treatment (iii)) or before oxytocin treatment (treatment (iv)). These data support the results of in vivo studies on the stimulatory effect of oxytocin on equine myometrium and indicate that progestagens are ineffective at controlling myometrial contractility in vitro. It is hypothesized that other hormones may be involved in this process.

The effects of oxytocin and progestagens on myometrial contractility in vitro during equine pregnancy.

Abstract

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief

Abstract

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief